Screener
Twist Bioscience Corporation TWST Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Total liabilities | $221,120 | $168,903 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity | ||
| Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at March 31, 2026 and September 30, 2025, respectively; 62,154 and 60,632 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively | $1 | — |
| Additional paid-in capital | 1,849,838 | 1,793,163 |
| Accumulated other comprehensive loss | (639) | (627) |
| Accumulated deficit | (1,394,106) | (1,319,578) |
| Total stockholders’ equity | $455,094 | $472,958 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's common stock?
- Twist Bioscience Corporation (TWST) reported common stock of 200M in Q1 2026.
- How has Twist Bioscience Corporation's common stock changed year-over-year?
- Twist Bioscience Corporation's common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Twist Bioscience Corporation's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude